Clinical Trial Update: Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating cytokine-induced memory-like natural killer (NK) cell adoptive therapy for relapsed acute myeloid leukemia after allogeneic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytokine Induced Memory-like NK Cell Adoptive Therapy

Snippet

Sponsor: Washington University School of Medicine | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-24